LH vs DGX — Key Metrics

Metric LH (LABCORP HOLDINGS INC) DGX (QUEST DIAGNOSTICS INC)
Price370.78259.69
Market Cap30.11 Billion28.57 Billion
P/E (TTM)30.2225.51
P/B (Quarterly)3.3173.487
P/S (TTM)2.062.41
Net Profit Margin (TTM)6.99.5
Gross Margin (TTM)29.033.1
ROE (TTM)11.515.2
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

LABCORP HOLDINGS INC
vs
 
QUEST DIAGNOSTICS INC
 
LABCORP HOLDINGS INC
vs
 
QUEST DIAGNOSTICS INC
Performance Comparison
AI Model Recommendation
LH · LABCORP HOLDINGS INC

Underperform

-32
UnderperformOutperform
DGX · QUEST DIAGNOSTICS INC

Underperform

-8
UnderperformOutperform
Recommendation Summary

Both stocks are projected to underperform the market over the next year. If you have to make a choice, Upfront Recommendation: DGX.

Financial Metrics
Prices delayed ~15 min
LH Metrics DGX
$370.78 Price $259.69
— Market Capitalization —
30.22 Price to Earnings Ratio 25.51
2.06 Price to Sales 2.41
23.4 Price to FCF Ratio 20.78
7.12 Price to Gross Profit 7.29
7.59 Price to Current Assets 9.17

LH vs DGX at a glance

Labcorp Holdings INC (LH) and Quest Diagnostics INC (DGX) are both Diagnostics & Research companies in the Healthcare sector. They are similar in size: $30.1 billion and $28.6 billion in market value.

On trailing-twelve-month figures, LH trades at 30.2 times trailing earnings and DGX at 25.5; net profit margins are 6.9% and 9.5%.

The Upfront Investment model currently rates both Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.